ArticleFrontiers in immunology2025

Tumor marker pseudoprogression and immune-related cholangitis during conversion therapy for massive hepatocellular carcinoma: a case report.

Xiaodong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.